Treatment targeted at a genetic mutation relieves psychosis symptoms

(Elsevier) Treatment of psychosis can be targeted to a specific genetic mutation in patients with psychotic disorders, according to a study in Biological Psychiatry, published by Elsevier. The study provides a proof-of-principle demonstration that treatments can be tailored to a specific genotype, rather than diagnosis, to relieve symptoms. The findings also link an individual structural mutation to the underlying biology of psychosis and treatment response.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2FSZ9gu